New experiences from global use of new tools in TB management and control

A. Khan (Karachi, Pakistan)

Source: Annual Congress 2013 –PG7 Tuberculosis: innovations in clinical and public health management
Session: PG7 Tuberculosis: innovations in clinical and public health management
Session type: Postgraduate Course
Number: 42
Disease area: Respiratory infections

PDF journal article, handout or slidesSlide presentationMultimedia files

Rating: 3.5
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
A. Khan (Karachi, Pakistan). New experiences from global use of new tools in TB management and control. Annual Congress 2013 –PG7 Tuberculosis: innovations in clinical and public health management

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
Ensuring rational introduction and responsible use of new TB tools: outcome of an ERS multisector consultation
Source: Eur Respir J 2014; 44: 1412-1417
Year: 2014


What next? Basic research, new treatments and a patient-centred approach in controlling tuberculosis
Source: Eur Respir Monogr 2018; 82: 414-429
Year: 2018


New perspectives in MDR-TB management
Source: International Congress 2016 – China Session II
Year: 2016


The effectiveness of the national program tuberculosis control in Ukraine and the future strategy
Source: Eur Respir J 2006; 28: Suppl. 50, 130s
Year: 2006

From patients to research laboratories and back: overview of the major scientific achievements and their impact in TB diagnosis, clinical management and control
Source: Annual Congress 2013 –The best of TB PANNET
Year: 2013


New approaches for evaluation of treatment effectiveness among patients with pulmonary TB under DOTS implemented conditions
Source: Eur Respir J 2002; 20: Suppl. 38, 368s
Year: 2002

New methodologogic approaches to the management of antituberculous service
Source: Eur Respir J 2003; 22: Suppl. 45, 381s
Year: 2003

Evaluating the potential costs and impact of digital health technologies for tuberculosis treatment support
Source: Eur Respir J, 52 (5) 1801363; 10.1183/13993003.01363-2018
Year: 2018



Current approaches to formulate evidence-based recommendations: a case study of WHO drug-resistant tuberculosis treatment guidance
Source: International Congress 2018 – Drug-resistant tuberculosis
Year: 2018



A global strategy for tuberculosis research and innovation
Source: Eur Respir J, 56 (5) 2003539; 10.1183/13993003.03539-2020
Year: 2020



Management of drug resistant pulmonary TB. New problems and perspectives
Source: Annual Congress 2009 - Multi/extensively-drug resistant tuberculosis
Year: 2009


New opportunities in tuberculosis control
Source: Eur Respir J 2012; 39: 1271-1273
Year: 2012


Therapeutic drug monitoring practice in patients with active tuberculosis: assessment of opportunities
Source: Eur Respir J, 57 (1) 2002349; 10.1183/13993003.02349-2020
Year: 2021



Scaling-up global implementation of LTBI management: a paradigm shift needed
Source: International Congress 2016 – ERS and tuberculosis
Year: 2016


The importance of long-term rational antibiotic use educational and control programmes among general practitioners
Source: Annual Congress 2009 - Medical education
Year: 2009


The standardised treatment of pulmonary TB: outcomes, problems and suggestions
Source: Annual Congress 2005 - PG10 - The management of tuberculosis: tradition and novelties
Year: 2005